Affimed

$5.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-1.83%) Today
-$0.22 (-4.10%) As of 1:06 PM UTC after-hours

Why Robinhood?

You can buy or sell Affimed and other stocks, options, and ETFs commission-free!

About AFMD

Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany. The listed name for AFMD is Affimed N.V.

CEO
Adolf Hoess
Employees
128
Headquarters
Heidelberg, Baden Wuerttemberg
Founded
2000
Market Cap
606.80M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.63M
High Today
$5.57
Low Today
$5.23
Open Price
$5.43
Volume
1.77M
52 Week High
$7.48
52 Week Low
$1.42

AFMD Earnings

-$0.21
-$0.14
-$0.07
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 27, Pre-Market

You May Also Like

SLGN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure